Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

Running trials

• Recruiting

  A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer

  NCT07895498· Phase 2· Source

• Recruiting

  A Study of Treatment Delivery Preference In People With Kidney Cancer

  NCT07872553· Phase 4· Source

• Recruiting

  A Study of Lung Cancer Risk

  NCT07701733· Source

• Recruiting

  A Study of a Side Effects and Resource Navigation Program for People With Cancer

  NCT07646847· Source

• Recruiting

  A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer

  NCT07619339· Phase 1· Source

• Recruiting

  A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

  NCT07594522· Phase 1/2· Source

• Recruiting

  A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer

  NCT07535463· Phase 1/2· Source

• Recruiting

  A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer

  NCT07535437· Phase 1/2· Source

• Recruiting

  A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

  NCT07532902· Phase 1· Source

• Recruiting

  A Study of Isoquercetin in People With Ovarian Cancer

  NCT07303894· Phase 2· Source

• Recruiting

  Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer

  NCT07218601· Phase 2· Source

• Recruiting

  A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

  NCT07052916· Source

• Recruiting

  A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas

  NCT07029217· Phase 3· Source

• Recruiting

  Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

  NCT06976476· Phase 2· Source

• Recruiting

  MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

  NCT06954337· Source

• Recruiting

  A Study of Ivonescimab in People With Endometrial and Cervical Cancers

  NCT06925724· Phase 2· Source

• Recruiting

  Acupuncture for People Experiencing Period Loss Due to Chemotherapy

  NCT06915116· Phase 2· Source

• Recruiting

  A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

  NCT06741085· Phase 2· Source

• Recruiting

  A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

  NCT06594991· Phase 2· Source

• Recruiting

  A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

  NCT06377566· Phase 2· Source

• Active, not recruiting

  A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers

  NCT06243757· Source

• Active, not recruiting

  A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

  NCT06132945· Phase 1· Source

• Recruiting

  A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

  NCT06055894· Source

• Recruiting

  Using Urine Samples to Identify Lung Cancer

  NCT06033248· Source

• Active, not recruiting

  A Study Comparing Mindfulness Apps to Decrease Anxiety in People With Lung Cancer

  NCT06008574· Source

• Recruiting

  A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

  NCT05691010· Early phase 1· Source

• Recruiting

  A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

  NCT05640843· Source

• Recruiting

  A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

  NCT05570253· Phase 2· Source

• Active, not recruiting

  A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

  NCT05169970· Phase 2· Source

• Active, not recruiting

  A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

  NCT04722172· Phase 2· Source

• Active, not recruiting

  A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer

  NCT04757363· Phase 2· Source

• Active, not recruiting

  The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)

  NCT04447768· Phase 2· Source

• Active, not recruiting

  Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer

  NCT04569773· Source

• Recruiting

  Collection of Information to Better Understand Young Onset Colorectal Cancer

  NCT04489238· Source

• Active, not recruiting

  Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

  NCT04468841· Phase 1· Source

• Active, not recruiting

  Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

  NCT04419519· Phase 2· Source

• Recruiting

  Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

  NCT04291612· Source

• Active, not recruiting

  Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

  NCT04288375· Phase 2· Source

• Active, not recruiting

  Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery

  NCT04161755· Phase 1· Source

• Active, not recruiting

  Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

  NCT03504163· Phase 2· Source

• Active, not recruiting

  A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

  NCT03520491· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer9 recruiting
• Multiple myeloma4 recruiting
• Endometrial cancer3 recruiting
• Bladder cancer2 recruiting
• Kidney cancer2 recruiting
• Cervical cancer1 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Follicular lymphoma1 recruiting
• Hodgkin lymphoma1 recruiting
• Melanoma1 recruiting
• Mesothelioma1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)

  NCT06333678· Phase 2· Source

• Terminated

  A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma

  NCT05788289· Phase 2· Source

• Completed

  Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the Liver

  NCT05182112· Phase 1· Source

• Completed

  A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer

  NCT04905316· Phase 2· Source

• Completed

  Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

  NCT04384146· Phase 1· Source

• Completed

  Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer

  NCT03956095· Source

• Completed

  A Study of Colesevelam for Lenalidomide-Associated Diarrhea

  NCT03767257· Phase 2· Source